Rates of Myocardial Infarction and Coronary Artery Disease and Risk Factors in Patients Treated With Radiation Therapy for Early-Stage Breast Cancer
Loading...
Files
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Open Access Color
BRONZE
Green Open Access
No
OpenAIRE Downloads
OpenAIRE Views
Publicly Funded
No
Abstract
We read the interesting article by Jagsi et al on the increased rates of coronary artery disease in patients treated with radiation therapy for early-stage breast cancer.1 In their study, those
authors concluded that the findings support further assessment of clinical outcomes when newer techniques of chemotherapy planning are employed as well as investigation of the potential role of innovative techniques. However, there was no mention of the novel radiosensitizing and chemosensitizing effects of bisphosphonates (BPs), which inhibit tumor cell adhesion to bone, and tumor growth in breast cancer.
Description
Correspondence
Keywords
Bisphosphonic acid derivative, Radiosensitizing agent, Zoledronic acid, Breast cancer, Cancer inhibition, Mice, Inbred BALB C, Bone Density Conservation Agents, Diphosphonates, Imidazoles, Myocardial Infarction, Breast Neoplasms, Coronary Artery Disease, Zoledronic Acid, Mice, Risk Factors, Animals, Humans
Fields of Science
03 medical and health sciences, 0302 clinical medicine
Citation
Ural, A. U., Avcu, F., and Baran, Y. (2007). Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer. Cancer, 110(2), 469-470. doi:10.1002/cncr.22804
WoS Q
Scopus Q

OpenCitations Citation Count
5
Source
Volume
110
Issue
2
Start Page
469
End Page
470
PlumX Metrics
Citations
CrossRef : 3
Scopus : 3
PubMed : 2
Captures
Mendeley Readers : 8
SCOPUS™ Citations
3
checked on Apr 27, 2026
Web of Science™ Citations
2
checked on Apr 27, 2026
Page Views
992
checked on Apr 27, 2026
Downloads
400
checked on Apr 27, 2026
Google Scholar™



